The number of private equity deals in the healthcare sector during the third quarter was down 28% from that of 2023’s second quarter, according to a report published Nov. 7 by market research firm PitchBook.
Hundreds of new ASCs have been proposed or developed so far in 2023, but a handful are sparking objections from state residents and competing health systems.
AmSurg named Jeff Snodgrass as its new CEO after the ASC operator emerged under new ownership as a separate entity from its former parent company Envision, which filed for bankruptcy.
Danville, Pa.-based Geisinger has been added to Capital Blue Cross’ Medicare Advantage network, beginning Jan. 1, according to a Nov. 9 report from The Valley Ledger.
Two business owners have pleaded guilty to buying and selling fake physician orders used to obtain more than $1.5 million in fraudulent Medicare payments.
Four major private equity deals shook up healthcare in the third quarter, according to Provident’s third-quarter “Mergers and Acquisitions Update” report.